Abstract
The paper describes the principal lines of development of nanocarriers for medical substances, morphological groups of nanocarriers, and influence of the physical and chemical properties of matrix substances on the key stages of the technological process. Technology aspects of manufacturing nanocarriers, differences in the conditions and techniques for polymer and lipid drug delivery systems are presented in detail.
Similar content being viewed by others
References
Ravi Kumar, M.N.V., Handbook of Particulate Drug Delivery, Am. Sci. Publ., 2008.
Golyshevskaya, V.I., Sevast’yanova, E.V., Irtuganova, O.A., et al., Probl. Tuberk. Boleznei Legkikh, 2006, no. 8, pp. 47–51.
Torchilin, V.P., Vysokomol. Soedin., 1994, no. 36, pp. 1880–1893.
Drummond, D.C., Meyer, O., Hong, K., et al., J. Pharmacol. Rev., 1999, vol. 51, pp. 691–744.
The Chemistry of Nanomaterials: Synthesis, Properties and Applications, Rao, C.N.R., Müller, A., and Cheetham, A.K., Eds., Weinheim: Wiley-VCH, 2006, vols. 1, 2.
Colin-de-Verdiere, A., Dubernet, C., Nemati, F., et al., Cancer Chem. Pharmacol., 1993, vol. 33, pp. 504–508.
Kreuter, J., Encyclopedia Nanosci. Nanotechnol., 2004, vol. 7, pp. 161–180.
Moghimi, S.M., Hunter, A.C., and Murray, J.C., Pharmacol. Rev., 2001, vol. 53, no. 2, pp. 283–318.
Salem, I., Flasher, D.L., and Duzgunes, N., Methods Enzymol., 2005, vol. 391, pp. 261–291.
Sun, L. and Chow, L.C., Dental Mater., 2008, vol. 24, no. 1, pp. 111–116.
Langer, K., Coester, C., Weber, C., et al., Eur. J. Pharmacol. Biopharmacol., 2000, vol. 49, pp. 303–307.
Vauthier, C., Ibid., 2003, vol. 55, pp. 519–548.
Ahlin, P., Kristl, J., Volk, B., et al., Int. J. Pharmacol., 2003, vol. 256, nos. 1–2, pp. 133–140.
Alyautdin, R.N., Doctoral (Med.) Dissertation, Moscow, 1999.
Chukwu, K., Ishroder, U., Sommerfeld, P., and Sabel, B.A., Proc. Int. Symp. Control. Rel. Bioact. Mater., 1999, vol. 26, pp. 1148–1149.
Wissing, S.A., Adv. Drug. Deliv. Rev., 2004, vol. 56, pp. 1257–1272.
Krpetic, Z., ScarÌ, G., Caneva, E., et al., Langmuir, 2009, ASAP, pp. 133–149.
Weerakody, R., Int. J. Pharm., 2008, vol. 357, p. 213.
Bassou, N., Langmuir, 2009, vol. 25, no. 1, p. 624.
Boguslavskii, L.I., Vestn. Mosk. Inst. Tonk. Khim. Tekhnol., 2010, vol. 5, no. 5, pp. 3–12.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E.V. Blynskaya, K.V. Alekseev, R.N. Alyautdin, 2010, published in Rossiiskii Khimicheskii Zhurnal, 2010, Vol. 54, No. 6, pp. 38–44.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Blynskaya, E.V., Alekseev, K.V. & Alyautdin, R.N. Perspectives of the development of pharmaceutical nanotechnology. Russ J Gen Chem 82, 519–526 (2012). https://doi.org/10.1134/S1070363212030309
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363212030309